These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Only the dopamine hypothesis in schizophrenia?]. Valchár M Cesk Psychiatr; 1987 Apr; 83(2):98-104. PubMed ID: 3581265 [No Abstract] [Full Text] [Related]
5. The dopamine hypothesis of schizophrenia and the antagonistic action of neuroleptic drugs--a review. Sayed Y; Garrison JM Psychopharmacol Bull; 1983; 19(2):283-8. PubMed ID: 6135238 [No Abstract] [Full Text] [Related]
6. Risk factors for schizophrenia--all roads lead to dopamine. Di Forti M; Lappin JM; Murray RM Eur Neuropsychopharmacol; 2007 Mar; 17 Suppl 2():S101-7. PubMed ID: 17336764 [TBL] [Abstract][Full Text] [Related]
7. The dopamine hypothesis: variations on a theme (II). Wyatt RJ Psychopharmacol Bull; 1986; 22(3):923-7. PubMed ID: 3797593 [No Abstract] [Full Text] [Related]
8. Commentary on "clinical studies on the mechanism of action of clozapine; the dopamine-serotonin hypothesis of schizophrenia." Psychopharmacology (1989) 99:S18-S27. Meltzer HY Psychopharmacology (Berl); 2002 Aug; 163(1):1-3. PubMed ID: 12185394 [No Abstract] [Full Text] [Related]
9. Assessment of dopaminergic function in schizophrenia [proceedings]. Angrist B; Rotrosen J; Gershon S Psychopharmacol Bull; 1980 Jan; 16(1):59-60. PubMed ID: 7360844 [No Abstract] [Full Text] [Related]
10. Neural circuitry models of schizophrenia: is it dopamine, GABA, glutamate, or something else? Benes FM Biol Psychiatry; 2009 Jun; 65(12):1003-5. PubMed ID: 19481640 [No Abstract] [Full Text] [Related]
11. Is elevated striatal dopamine function a prodromal sign of schizophrenia? Simon AE; Umbricht D Arch Gen Psychiatry; 2009 Aug; 66(8):916-7. PubMed ID: 19652133 [No Abstract] [Full Text] [Related]
12. Gaba blockade, dopamine and schizophrenia: experimental activation of the mesolimbic system. Stevens JR Int J Neurol; 1975; 10(1-4):115-27. PubMed ID: 1237474 [No Abstract] [Full Text] [Related]
13. Adaptation of the dopaminergic system in the pathophysiology and treatment of schizophrenia. Introduction. Friedhoff AJ Psychopharmacol Bull; 1988; 24(3):335-7. PubMed ID: 3153489 [No Abstract] [Full Text] [Related]
14. [Dopaminergic receptor activity and the evolution of schizophrenia]. Fodoreanu L Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1985; 30(2):131-4. PubMed ID: 2864729 [No Abstract] [Full Text] [Related]
15. Dopamine and CNV: studies of drugs, disease and nutrition. Tecce JJ Electroencephalogr Clin Neurophysiol Suppl; 1991; 42():153-64. PubMed ID: 1680669 [No Abstract] [Full Text] [Related]
18. Schizophrenia and DA-hypothesis: pathological and therapeutic aspects. 9th annual meeting of the Belgian College of Neuropsychopharmacological and Biological Psychiatry. Louvain-en-Woluwe, 21 November 1986. Proceedings. Acta Psychiatr Belg; 1987; 87(5):521-617. PubMed ID: 3451673 [No Abstract] [Full Text] [Related]